Screening Strategies in Drug Discovery – News and Features
News
Cytomics Systems Completes € 10 Million Round of Financing
This round will enable the company to accelerate the development of its antifungal compounds.
News
Reaction Biology Awarded NIH R01 Screening Roadmap Grant
The Grant is awarded to accelerate development of RBC’s DiscoveryDot™ High Throughput Screening technology.
News
Open Biosystems Signs Northwestern University to Open Access RNAi Program
Northwestern's community of 270 participating research labs gain access to the advanced RNAi technology.
News
CyBio Announces Distribution Agreement with Liconic
CyBio obtained the exclusive right to market Liconics product portfolio in France.
News
IPK and Euroscreen Form Alliance for GPCR Drug Discovery
This partnership highlights the interest in visual-based screening technologies to identify selective drug candidates.
News
ChemDiv to Provide the German National Compound Library
The library will represent about 80% of compounds of the central compound library for basic research.
News
Peakdale Extends its Range of Medicinal Chemistry Services
The services enable the Company to provide compounds with a starting point for hit discovery.
News
Evotec and Apeiron to Discover Pain Therapeutics
Apeiron and Evotec will jointly develop tailored biochemical and cellular assays.
News
Sigma and Genospectra Signs Agreements to Expand Position in RNAi and Cell Based Assays
Sigma-Aldrich will gain access to the QuantiGene gene expression profiling assay and Genospectra's technologies.
News
Scripps Florida Selects GenoLogics Platform for Proteomics and Systems Biology Research
The proteomics program at Scripps Florida is focusing on developing and applying technologies in mass spectrometry-based proteomics.
Advertisement
